spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PRISYM ID to Exhibit at the Clinical Trials Supply Nordics Event

PRISYM ID

PRISYM ID, leading provider of labelling solutions for the life sciences industries, is exhibiting at The Clinical Trial Supply Event in Copenhagen, Denmark on the 7/8th June 2017, on stand 6

30th May 2017:  PRISYM ID, leading provider of labelling solutions for the life sciences industries, is exhibiting at The Clinical Trial Supply Event in Copenhagen, Denmark on the 7/8th June 2017, on stand 6.

The 2017 event programme will host a variety of speakers from a number of leading pharmaceutical companies as well as a number of small to mid-sized biotechs. This two-day event will focus on the top issues facing the industry such as label simplification to improve efficiency and cold chain management for safeguarding products. These challenges will be addressed through interactive presentations and engaging panel discussions. There will also be stimulating roundtable discussions on both days, allowing attendees to debate possible solutions in smaller groups.

This is a great opportunity for Clinical Trial organisations to hear more about the latest Clinical Trial Management module update PRISYM ID launched, in addition to its renowned, flagship solution, PRISYM 360, to further transform global Label Lifecycle Management.

Unlike traditional label design tools, PRISYM 360 is an enterprise-class solution designed specifically for, and in partnership with, the life science industry. The addition of its Clinical Trial Management module provides out-of- the-box clinical labelling data structures and tools based on clinical study best practice, allowing clinical research teams to design and print compliant labels quickly and effectively.

The event offers a perfect platform for collaborating and building relationships between attendees and PRISYM ID to facilitate the formation of new partnerships and strengthening existing relationships.

For more information about PRISYM ID and to arrange a meeting during the event, please contact info@prisymid.com or call +44 (0)118 936 4400

About PRISYM ID
World Class Label Management Software
PRISYM ID designs and delivers label management software for organizations that need complete product auto-identification and lifecycle traceability. With the continual tightening of labeling regulations and audits, PRISYM ID empowers its clients to safeguard their reputation by ensuring compliance, removing risk and significantly reduce costs by eliminating recalls through labeling errors. PRISYM ID is the market leader in providing validatable world-class label lifecycle management, and is trusted for delivering personalized service excellence to clients.

http://www.prisymid.com/

phone +44 (0) 118 936 4400
email info@prisymid.com
web www.prisymid.com/
email TECH House, Oaklands Business Centre, Oaklands Park, Wokingham, Berkshire, RG41 2FD, UK
 
Print this page
Send to a friend
   
spacer
News and Press Releases

New Study Demonstrates: WACKER’s Antioxidant HTEssence® Lowers LDL Cholesterol Significantly

At Supply Side West 2017, WACKER is presenting new results on the effect of its nature-identical hydroxytyrosol HTEssence® on heart health. A recent human clinical study demonstrates that HTEssence® is able to significantly reduce LDL (low density lipoprotein) cholesterol. Reducing LDL has been found to support heart health. Hydroxytyrosol is a highly effective antioxidant found in olives with positive effects on blood pressure, joints and the immune and cardiovascular systems. WACKER is producing the first nature-identical hydroxytyrosol free of unwanted byproducts and with a defined amount of active ingredient. HTEssence® offers an excellent price/performance ratio and is easy to process in dietary supplements and functional beverages. WACKER will be exhibiting this product at SupplySide West in Las Vegas, Nevada (USA), from September 27-29, 2017.
More info >>


White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

Industry Events

9th Global Drug Delivery & Formulation Summit

12-14 March 2018, Maritim proArte Hotel Berlin

The DDF Summit brings the most interesting studies and exciting technologies to you. This year there will be 4 dedicated streams focusing on Small Molecules, Biologics, Technology & Innovation and for the first-time Device Development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement